Corteva (CTVA)
(Delayed Data from NYSE)
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$58.95 USD
0.00 (0.00%)
Updated Oct 17, 2024 04:02 PM ET
After-Market: $58.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Zacks News
Is Corteva (CTVA) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and Sanderson Farms (SAFM) have performed compared to their sector so far this year.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Corteva, Inc. (CTVA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Corteva, Inc. (CTVA) closed the most recent trading day at $52.24, moving +0.46% from the previous trading session.
Things to Note as Philip Morris (PM) Lines Up for Q2 Earnings
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2022 results are likely to reflect cost concerns and certain hurdles related to the pandemic, whereas strong pricing is likely to have remained an upside.
Corteva, Inc. (CTVA) Stock Moves -0.66%: What You Should Know
by Zacks Equity Research
In the latest trading session, Corteva, Inc. (CTVA) closed at $52.56, marking a -0.66% move from the previous day.
Things to Note as Conagra Brands (CAG) Lines Up for Q4 Earnings
by Zacks Equity Research
Conagra Brands' (CAG) fourth-quarter fiscal 2022 results will likely reflect robust consumer demand. The company's pricing and saving efforts will likely offer some respite amid rising costs.
Corteva, Inc. (CTVA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Corteva, Inc. (CTVA) closed at $52.04, marking a -0.12% move from the previous day.
Has Corteva (CTVA) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Corteva, Inc. (CTVA) and Sanderson Farms (SAFM) have performed compared to their sector so far this year.
Corteva, Inc. (CTVA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Corteva, Inc. (CTVA) closed at $54.24, marking a +1.27% move from the previous day.
McCormick (MKC) Queued for Q2 Earnings: Things to Consider
by Zacks Equity Research
McCormick's (MKC) second-quarter fiscal 2022 performance is likely to reflect gains from increased demand. However, escalated cost inflation might be a hurdle.
Things to Note Before Constellation Brands' (STZ) Q1 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results are expected to reflect gains from strength in the beer business and strong consumer demand amid softness in the Wine & Spirits business and supply-chain headwinds.
Corteva, Inc. (CTVA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Corteva, Inc. (CTVA) closed the most recent trading day at $53.22, moving -1.52% from the previous trading session.
Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower
by Zacks Equity Research
Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower have been highlighted in this Industry Outlook article.
Corteva, Inc. (CTVA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Corteva, Inc. (CTVA) closed at $56.39 in the latest trading session, marking a +0.27% move from the prior day.
5 Stocks to Watch on Robust Agriculture Operations Industry Trends
by Rajani Lohia
The Agriculture - Operations industry shows potential on solid demand trends, organic product growth and innovation ability. Players like ADM, CTVA, YTEN, AGRO and CVGW have placed themselves well.
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
DOLE vs. CTVA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
Corteva, Inc. (CTVA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 19.75% and 1.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Higher Costs Mar Monster Beverage's (MNST) Earnings in Q1?
by Zacks Equity Research
Strength in the energy drinks business and higher demand are likely to have boosted Monster Beverage's (MNST) sales in Q1. Higher operating costs and supply-chain headwinds are expected to have hurt.
AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?
by Zacks Equity Research
AB InBev's (BUD) Q1 results are expected to reflect gains from volume, pricing and revenue per hl growth, as well as strength in the beer category, amid supply-chain and cost headwinds.
Clorox (CLX) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in third-quarter fiscal 2022. Nonetheless, its IGNITE strategy appears encouraging.
Factors Likely to Influence Molson Coors' (TAP) Q1 Earnings
by Zacks Equity Research
Molson Coors (TAP) Q1 results are likely to reflect gains from the revitalization plan and portfolio premiumization. Higher marketing and inflationary costs are likely to have hurt performance.
FEMSA (FMX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
FEMSA's (FMX) Q1 results are expected to reflect gains from strength across business units, market recovery, digital growth and expansion amid supply-chain woes and higher raw material costs.